Section Arrow
QNTM.NASDAQ
- Quantum Biopharma Ltd
Quotes are at least 15-min delayed:2025/06/24 20:24 EDT
Last
 27.13
+4.12 (+17.91%)
Day High 
29 
Prev. Close
23.01 
1-M High
38.25 
Volume 
626.46K 
Bid
27
Ask
28
Day Low
25.25 
Open
25.25 
1-M Low
10.75 
Market Cap 
66.90M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 21.92 
20-SMA 17.72 
50-SMA 11.98 
52-W High 38.25 
52-W Low 2.7 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-13.22/--
Enterprise Value
66.90M
Balance Sheet
Book Value Per Share
1.97
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PSTVPlus Therapeutics0.187+0.0027+1.47%-- 
VORVor Biopharma0.3181+0.0281+9.69%-- 
IBIOiBio0.748+0.0356+5.00%0.65PE
NCNANuCana plc0.0905+0.0016+1.80%-- 
ADILAdial Pharmaceuticals0.2293-0.0337-12.81%-- 
Quotes are at least 15-min delayed:2025/06/24 20:24 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.